Click for best price
Antiinfluenza Drugs Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Anti-influenza Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-influenza Drugs. This report contains market size and forecasts of Anti-influenza Drugs in global, including the following market information:
Global Anti-influenza Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Anti-influenza Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oseltamivir Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Anti-influenza Drugs include Roche, HEC Pharm, Shanghai Zhongxisanwei, GlaxoSmithKline, Guangzhou Pharmaceutical and Hunan Nucien Pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Anti-influenza Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Anti-influenza Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Anti-influenza Drugs Market Segment Percentages, by Type, 2022 (%)
Oseltamivir
Zanamivir
Peramivir
Other
Global Anti-influenza Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Anti-influenza Drugs Market Segment Percentages, by Application, 2022 (%)
Children
Adults
Elderly
Global Anti-influenza Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Anti-influenza Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-influenza Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Anti-influenza Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
HEC Pharm
Shanghai Zhongxisanwei
GlaxoSmithKline
Guangzhou Pharmaceutical
Hunan Nucien Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Anti-influenza Drugs, market overview.
Chapter 2: Global Anti-influenza Drugs market size in revenue.
Chapter 3: Detailed analysis of Anti-influenza Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Anti-influenza Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Anti-influenza Drugs Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Anti-influenza Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Anti-influenza Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Anti-influenza Drugs Overall Market Size
2.1 Global Anti-influenza Drugs Market Size: 2022 VS 2029
2.2 Global Anti-influenza Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Anti-influenza Drugs Players in Global Market
3.2 Top Global Anti-influenza Drugs Companies Ranked by Revenue
3.3 Global Anti-influenza Drugs Revenue by Companies
3.4 Top 3 and Top 5 Anti-influenza Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Anti-influenza Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Anti-influenza Drugs Players in Global Market
3.6.1 List of Global Tier 1 Anti-influenza Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Anti-influenza Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Anti-influenza Drugs Market Size Markets, 2022 & 2029
4.1.2 Oseltamivir
4.1.3 Zanamivir
4.1.4 Peramivir
4.1.5 Other
4.2 By Type - Global Anti-influenza Drugs Revenue & Forecasts
4.2.1 By Type - Global Anti-influenza Drugs Revenue, 2018-2023
4.2.2 By Type - Global Anti-influenza Drugs Revenue, 2024-2029
4.2.3 By Type - Global Anti-influenza Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Anti-influenza Drugs Market Size, 2022 & 2029
5.1.2 Children
5.1.3 Adults
5.1.4 Elderly
5.2 By Application - Global Anti-influenza Drugs Revenue & Forecasts
5.2.1 By Application - Global Anti-influenza Drugs Revenue, 2018-2023
5.2.2 By Application - Global Anti-influenza Drugs Revenue, 2024-2029
5.2.3 By Application - Global Anti-influenza Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Anti-influenza Drugs Market Size, 2022 & 2029
6.2 By Region - Global Anti-influenza Drugs Revenue & Forecasts
6.2.1 By Region - Global Anti-influenza Drugs Revenue, 2018-2023
6.2.2 By Region - Global Anti-influenza Drugs Revenue, 2024-2029
6.2.3 By Region - Global Anti-influenza Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Anti-influenza Drugs Revenue, 2018-2029
6.3.2 US Anti-influenza Drugs Market Size, 2018-2029
6.3.3 Canada Anti-influenza Drugs Market Size, 2018-2029
6.3.4 Mexico Anti-influenza Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Anti-influenza Drugs Revenue, 2018-2029
6.4.2 Germany Anti-influenza Drugs Market Size, 2018-2029
6.4.3 France Anti-influenza Drugs Market Size, 2018-2029
6.4.4 U.K. Anti-influenza Drugs Market Size, 2018-2029
6.4.5 Italy Anti-influenza Drugs Market Size, 2018-2029
6.4.6 Russia Anti-influenza Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Anti-influenza Drugs Market Size, 2018-2029
6.4.8 Benelux Anti-influenza Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Anti-influenza Drugs Revenue, 2018-2029
6.5.2 China Anti-influenza Drugs Market Size, 2018-2029
6.5.3 Japan Anti-influenza Drugs Market Size, 2018-2029
6.5.4 South Korea Anti-influenza Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Anti-influenza Drugs Market Size, 2018-2029
6.5.6 India Anti-influenza Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Anti-influenza Drugs Revenue, 2018-2029
6.6.2 Brazil Anti-influenza Drugs Market Size, 2018-2029
6.6.3 Argentina Anti-influenza Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Anti-influenza Drugs Revenue, 2018-2029
6.7.2 Turkey Anti-influenza Drugs Market Size, 2018-2029
6.7.3 Israel Anti-influenza Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Anti-influenza Drugs Market Size, 2018-2029
6.7.5 UAE Anti-influenza Drugs Market Size, 2018-2029
7 Anti-influenza Drugs Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Anti-influenza Drugs Major Product Offerings
7.1.4 Roche Anti-influenza Drugs Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 HEC Pharm
7.2.1 HEC Pharm Company Summary
7.2.2 HEC Pharm Business Overview
7.2.3 HEC Pharm Anti-influenza Drugs Major Product Offerings
7.2.4 HEC Pharm Anti-influenza Drugs Revenue in Global Market (2018-2023)
7.2.5 HEC Pharm Key News & Latest Developments
7.3 Shanghai Zhongxisanwei
7.3.1 Shanghai Zhongxisanwei Company Summary
7.3.2 Shanghai Zhongxisanwei Business Overview
7.3.3 Shanghai Zhongxisanwei Anti-influenza Drugs Major Product Offerings
7.3.4 Shanghai Zhongxisanwei Anti-influenza Drugs Revenue in Global Market (2018-2023)
7.3.5 Shanghai Zhongxisanwei Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Anti-influenza Drugs Major Product Offerings
7.4.4 GlaxoSmithKline Anti-influenza Drugs Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 Guangzhou Pharmaceutical
7.5.1 Guangzhou Pharmaceutical Company Summary
7.5.2 Guangzhou Pharmaceutical Business Overview
7.5.3 Guangzhou Pharmaceutical Anti-influenza Drugs Major Product Offerings
7.5.4 Guangzhou Pharmaceutical Anti-influenza Drugs Revenue in Global Market (2018-2023)
7.5.5 Guangzhou Pharmaceutical Key News & Latest Developments
7.6 Hunan Nucien Pharmaceutical
7.6.1 Hunan Nucien Pharmaceutical Company Summary
7.6.2 Hunan Nucien Pharmaceutical Business Overview
7.6.3 Hunan Nucien Pharmaceutical Anti-influenza Drugs Major Product Offerings
7.6.4 Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue in Global Market (2018-2023)
7.6.5 Hunan Nucien Pharmaceutical Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Anti-influenza Drugs Market Opportunities & Trends in Global Market
Table 2. Anti-influenza Drugs Market Drivers in Global Market
Table 3. Anti-influenza Drugs Market Restraints in Global Market
Table 4. Key Players of Anti-influenza Drugs in Global Market
Table 5. Top Anti-influenza Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Anti-influenza Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Anti-influenza Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Anti-influenza Drugs Product Type
Table 9. List of Global Tier 1 Anti-influenza Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-influenza Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Anti-influenza Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Anti-influenza Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Anti-influenza Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Anti-influenza Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Anti-influenza Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Anti-influenza Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Anti-influenza Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Anti-influenza Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Anti-influenza Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Anti-influenza Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Anti-influenza Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Anti-influenza Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Anti-influenza Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Anti-influenza Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Anti-influenza Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Anti-influenza Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Anti-influenza Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Anti-influenza Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Anti-influenza Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Anti-influenza Drugs Product Offerings
Table 32. Roche Anti-influenza Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. HEC Pharm Company Summary
Table 35. HEC Pharm Anti-influenza Drugs Product Offerings
Table 36. HEC Pharm Anti-influenza Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. HEC Pharm Key News & Latest Developments
Table 38. Shanghai Zhongxisanwei Company Summary
Table 39. Shanghai Zhongxisanwei Anti-influenza Drugs Product Offerings
Table 40. Shanghai Zhongxisanwei Anti-influenza Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Shanghai Zhongxisanwei Key News & Latest Developments
Table 42. GlaxoSmithKline Company Summary
Table 43. GlaxoSmithKline Anti-influenza Drugs Product Offerings
Table 44. GlaxoSmithKline Anti-influenza Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. GlaxoSmithKline Key News & Latest Developments
Table 46. Guangzhou Pharmaceutical Company Summary
Table 47. Guangzhou Pharmaceutical Anti-influenza Drugs Product Offerings
Table 48. Guangzhou Pharmaceutical Anti-influenza Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Guangzhou Pharmaceutical Key News & Latest Developments
Table 50. Hunan Nucien Pharmaceutical Company Summary
Table 51. Hunan Nucien Pharmaceutical Anti-influenza Drugs Product Offerings
Table 52. Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Hunan Nucien Pharmaceutical Key News & Latest Developments
List of Figures
Figure 1. Anti-influenza Drugs Segment by Type in 2022
Figure 2. Anti-influenza Drugs Segment by Application in 2022
Figure 3. Global Anti-influenza Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Anti-influenza Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Anti-influenza Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Anti-influenza Drugs Revenue in 2022
Figure 8. By Type - Global Anti-influenza Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Anti-influenza Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Anti-influenza Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Anti-influenza Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Anti-influenza Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Anti-influenza Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Anti-influenza Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Anti-influenza Drugs Revenue Market Share, 2018-2029
Figure 16. US Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Anti-influenza Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Anti-influenza Drugs Revenue Market Share, 2018-2029
Figure 28. China Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Anti-influenza Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Anti-influenza Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Anti-influenza Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Anti-influenza Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. HEC Pharm Anti-influenza Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Shanghai Zhongxisanwei Anti-influenza Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. GlaxoSmithKline Anti-influenza Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Guangzhou Pharmaceutical Anti-influenza Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Hunan Nucien Pharmaceutical Anti-influenza Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
